Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Insurance Australia Group (IAG.AX)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (A$) Price Target (A$) Rating
2022-02-184.764.20Sell
2022-04-064.384.10Sell
2022-08-124.664.20Sell
2023-02-014.914.40Sell
2023-02-034.734.20Sell
2023-02-134.924.30Sell
2023-06-145.234.70Sell
2023-07-075.734.80Sell
2023-08-215.795.10Sell
2023-12-055.926.00Neutral
2024-04-306.446.50Neutral
2024-06-287.147.10Neutral
2024-10-297.558.15Neutral
2024-11-288.478.55Neutral
2025-02-019.209.15Neutral
2025-02-137.808.60Neutral
2025-04-027.798.50Neutral
2025-04-097.468.30Buy
2025-05-168.659.30Neutral

Disclosures

  • UBS has acted as manager/co-manager in the underwriting or placement of securities of this company/entity or one of its affiliates within the past 12 months.
  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS Securities Australia Limited is acting as broker to Insurance Australia Group on its on market buyback and may receive a fee for this service
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.